Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats
- PMID: 21495263
- DOI: 10.1007/s13318-010-0004-y
Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats
Abstract
Facial injuries are critical conditions, leading to serious complications, such as occult facial infections. Infectious endophthalmitis occurs despite of antibiotics use during implantation of intraocular lenses and is generally resistant to antibiotic therapy. It is a crucial situation in ophthalmology, since it often induces a substantial reduction of visual acuity and in some cases the loss of the eye despite treatment. It is, therefore, important to obtain drug levels able to exert antimicrobial effect in the diseased organ. The distribution of a drug depends on the binding extent to both plasma proteins and tissues and only the free drug is capable to be transported/diffused across membranes from blood vessels into tissues, in order to achieve its effect on the target organ. Hyperlipidaemia and consequent enhanced concentration of free fatty acid can modify binding pharmacokinetics of antibiotics through antagonism for the same binding sites. Cefotaxime, the third generation cephalosporin with easy penetration in a variety of tissues and body fluids and low incidence of adverse effects, can obtain adequate concentration in blood, eye bulb, and in the orbital bones. Its levels are influenced by hyperlipidaemia with clinical impact.
Similar articles
-
How harmless is FFA enhancement?Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):213-5. doi: 10.1007/BF03189715. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8980917
-
Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):635-645. doi: 10.1007/s13318-016-0375-9. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27686853
-
Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis).J Vet Sci. 2006 Jun;7(2):119-22. doi: 10.4142/jvs.2006.7.2.119. J Vet Sci. 2006. PMID: 16645334 Free PMC article. Clinical Trial.
-
Cefotaxime: microbiology, pharmacology, and clinical use.Clin Pharm. 1982 Mar-Apr;1(2):114-24. Clin Pharm. 1982. PMID: 6309465 Review.
-
Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.Ann Pharmacother. 2008 Jan;42(1):71-9. doi: 10.1345/aph.1H620. Epub 2007 Dec 19. Ann Pharmacother. 2008. PMID: 18094350 Review.
References
-
- Am J Physiol Regul Integr Comp Physiol. 2001 Jan;280(1):R56-61 - PubMed
-
- Eur J Drug Metab Pharmacokinet. 2005 Jul-Sep;30(3):171-4 - PubMed
-
- Invest Ophthalmol Vis Sci. 1999 Aug;40(9):2010-8 - PubMed
-
- J Antimicrob Chemother. 2009 Mar;63(3):480-4 - PubMed
-
- Ophthalmic Plast Reconstr Surg. 1987;3(4):231-5 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical